Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
09/2008
09/12/2008WO2008109349A1 Improved regimen for treating cancer with 5-fluorouracil, 5,10-methylenetetrahydrofolate and capecitabine
09/12/2008WO2008109343A1 Methods of treating bipolar disorder and memory and/or cognitive impairment associated therewith with (+)-isopropyl 2-methoxyethyl 4-(2-chloro-3-cyano-phenyl)-1,4-dihydro-2,6-dimethyl-pyridine-3,5-dicarboxylate
09/12/2008WO2008109336A1 Tetrahydroisoquinoline compounds as modulators of the histamine h3 receptor
09/12/2008WO2008109334A1 Novel crystalline salt form of an antidiabetic compound
09/12/2008WO2008109333A1 Indole and benzothiophene compounds as modulators of the histamine h3 receptor
09/12/2008WO2008109314A1 Heterocyclic compounds, compositions comprising them and methods of their use
09/12/2008WO2008109287A1 Methods for treating cognitive disorders using 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
09/12/2008WO2008109286A1 Methods for treating cognitive disorders using 1-aryl-1-hydroxy-2,3-diamino-propyl amines, 1-heteroaryl-1-hydroxy-2,3-diamino-propyl amines and related compounds
09/12/2008WO2008109285A1 Methods for treating cognitive disorders
09/12/2008WO2008109238A1 Substituted cyclopentyl piperidine ccr2 antagonists
09/12/2008WO2008109184A1 Heterocyclic cyclopamine analogs and methods of use thereof
09/12/2008WO2008109179A1 Metalloprotease inhibitors containing a squaramide moiety
09/12/2008WO2008109175A1 Deuterated piperazine derivatives as anti-anginal compounds
09/12/2008WO2008109163A1 Nanoparticle comprising rapamycin and albumin as anticancer agent
09/12/2008WO2008109154A1 Chemokine receptor modulators
09/12/2008WO2008109124A1 Use of nitroglycerin to reverse local anesthesia
09/12/2008WO2008109104A1 Bivalent inhibitors of akt protein kinase
09/12/2008WO2008109076A1 Methods for enhancing the efficacy of vascular disrupting agents
09/12/2008WO2008109056A1 Sulfonylated heterocycles useful for modulation of the progesterone receptor
09/12/2008WO2008109027A2 Tri-aryl/heteroaroaromatic cannabinoids and use thereof
09/12/2008WO2008109026A1 Pharmaceutical compositions for the localized treatment of neurogenic dysfunction
09/12/2008WO2008109018A1 Compositions comprising carisoprodol and methods of use thereof
09/12/2008WO2008109007A1 Bridged phenanthridines
09/12/2008WO2008108991A1 Bipyridine carboxamide orexin receptor antagonists
09/12/2008WO2008108988A1 Antimicrobial heterocyclic compounds for treatment of bacterial infections
09/12/2008WO2008108958A2 Benzimidazole derivatives and methods of use thereof
09/12/2008WO2008108957A2 Piperidinyl-piperidine and piperazinyl-piperidine for use in the treatment of diabetes or pain
09/12/2008WO2008108937A1 Method of making porphyrins
09/12/2008WO2008108908A2 Cellulose acetate 1,2-benzenedicarboxylate cosmeceutical
09/12/2008WO2008108842A1 Lisofylline analogs and methods for use
09/12/2008WO2008108825A2 Neuroprotective compositions and methods
09/12/2008WO2008108824A2 Lumped plasmonic diode and lumped plasmonic rectifier
09/12/2008WO2008108793A2 Prevention of nuclear, solar, and other radiation-induced tissue damage
09/12/2008WO2008108742A2 Polymorphic forms of clopidogrel hydrobromide
09/12/2008WO2008108741A1 Combination of benzimidazole anti-cancer agent and a second anti-cancer agent
09/12/2008WO2008108735A1 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel disease
09/12/2008WO2008108730A1 Novel 2-heteroaryl substituted benzothiophenes and benzofuranes 709
09/12/2008WO2008108729A1 Novel 2-heteroaryl substituted indoles 695
09/12/2008WO2008108689A2 Mix for identification test in the process of quality control of the medicine 'glycine tablets for sublingual applying 0,1g' methods of its preparation and identity evaluation in the process of quality control of the aforementioned medicine
09/12/2008WO2008108647A2 Enhancement of anticancer therapy by flavonoids
09/12/2008WO2008108639A1 Co-crystalline forms of carbamazepine
09/12/2008WO2008108630A1 Polymorphic forms of efavirenz
09/12/2008WO2008108508A1 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient
09/12/2008WO2008108486A1 1-biarylazetidinone derivatives
09/12/2008WO2008108448A1 Isoxazoline-substituted benzamide compound and pest control agent
09/12/2008WO2008108445A1 Benzoxazepine derivatives and use thereof
09/12/2008WO2008108424A1 Device for the transdermal administration of bisoprolol
09/12/2008WO2008108386A1 Pharmaceutical composition
09/12/2008WO2008108380A2 Pyrrole compounds
09/12/2008WO2008108323A1 Drug for treatment of influenza
09/12/2008WO2008108322A2 Composition and method for protecting mitochondria
09/12/2008WO2008108309A1 Fused pyridine derivative
09/12/2008WO2008108291A1 Process for production of prasugrel hydrochloride having high purity
09/12/2008WO2008108286A1 Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same
09/12/2008WO2008108262A1 Immunomodulating agent
09/12/2008WO2008107910A2 Use of caralluma extracts in the inhibition of adipogenesis and a method of inhibition for the same
09/12/2008WO2008107909A1 Pharmaceutical compositions comprising trigonelline and 4-hydroxyisoleucine and a process thereof
09/12/2008WO2008107901A2 Agents, compositions and methods for treating pathologies in which regulating an ache-associated biological pathway is beneficial
09/12/2008WO2008107879A1 Novel cannabidiol derivatives and their use as anti-inflammatory agents
09/12/2008WO2008107878A1 Novel quinonoid derivatives of cannabinoids and their use in the treatment of malignancies
09/12/2008WO2008107873A1 Mercaptopurine derivatives as anticancer agents
09/12/2008WO2008107797A2 Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
09/12/2008WO2008107777A2 Improved method for the preparation of desloratadine with reduced levels of organic solvents
09/12/2008WO2008107771A2 2',3'-di-o-acyl-5-fluoronucleosides
09/12/2008WO2008107661A1 New methylenebisphenyl compounds useful in the treatment of inflammation
09/12/2008WO2008107544A1 Derivatives of n-(heteroaryl)-1-heteroaryl-1h-indol-2-carboxamids, preparation thereof and therapeutic use thereof
09/12/2008WO2008107503A1 Use of compounds for treating infectious diseases caused by helicobacter pylori
09/12/2008WO2008107481A1 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives
09/12/2008WO2008107480A1 1,4-disubstituted 3-cyano-pyridone derivatives and their use as positive mglur2 -receptor modulators
09/12/2008WO2008107479A1 3-cyano-4-(4-phenyl-piperidin-1-yl)-pyridin-2-one derivatives
09/12/2008WO2008107478A1 Quinolinone derivatives as parp and tank inhibitors
09/12/2008WO2008107455A1 Indazoles used to treat estrogen receptor beta mediated disorders
09/12/2008WO2008107452A1 Pharmaceutical composition comprising a salt of rosiglitazone
09/12/2008WO2008107446A1 Use of lhrh antagonists for the treatment of lower urinary tract symptoms, in particular overactive bladder and/or detrusor overactivity
09/12/2008WO2008107444A1 9h- purine derivatives and their use in the treatment of proliferative diseases
09/12/2008WO2008107436A1 Bicyclic organic compounds suitable for the treatment of inflammatory or allergic conditions
09/12/2008WO2008107418A1 Fused pyrimidinone compounds as mglur ligands
09/12/2008WO2008107416A1 Target of rapamycin modulators of and use thereof
09/12/2008WO2008107410A1 Analgesic composition of topically applied nonsteroidal antiinflammatory drugs and opioids
09/12/2008WO2008107399A1 Substituted oxindole compounds
09/12/2008WO2008107390A1 Pharmaceutical compositions comprising a calcilytic agent
09/12/2008WO2008107373A1 Mineralcorticoid receptor antagonists for the treatment of endometriosis
09/12/2008WO2008107368A1 Purines as cysteine protease inhibitors
09/12/2008WO2008107365A1 New compounds
09/12/2008WO2008107363A1 New blood coagulation factor inhibitors
09/12/2008WO2008107335A1 Aminoamides as orexin antagonists
09/12/2008WO2008107334A2 Process for the synthesis of glyt-1 inhibitors
09/12/2008WO2008107321A1 Heterocyclic compounds used as anti-neoplasic agents or cell proliferation inhibitors
09/12/2008WO2008107320A1 Piperidine and piperazine derivatives used as anti-neoplasic agents or cell proliferation inhibitors
09/12/2008WO2008107301A2 Rapid-disintegration monolayer film for the oral administration of active substances
09/12/2008WO2008107271A1 Imprinted polymers
09/12/2008WO2008107211A2 Novel p2y12 receptor antagonists
09/12/2008WO2008107197A2 Nutrient compositions
09/12/2008WO2008107193A1 Topical composition comprising retinoid receptor agonist for treatment of acne
09/12/2008WO2008107179A1 Pharmaceutical formulation comprising a cb1-receptor compound in a solid solution and/or solid dispersion
09/12/2008WO2008107176A1 Meta-substituted phenyl sulfonyl amides of secondary amino acid amides, the production thereof, and use thereof as matriptase inhibitors
09/12/2008WO2008107152A1 Process for the manufacture of a powder containing carotenoids
09/12/2008WO2008107149A2 Pharmaceutical form with impeded abuse
09/12/2008WO2008107125A1 New 3-([1,2,4]triazolo[4,3-a]pyridin-7-yl)benzamide derivatives
09/12/2008WO2008107099A1 Drug comprising at least one gestagen
1 ... 3088 3089 3090 3091 3092 3093 3094 3095 3096 3097 3098 3099 3100 3101 3102 3103 3104 3105 3106 3107 3108 ... 7860